Answer
Vocabria (cabotegravir) injections must be administered at the ventrogluteal site (recommended) or the dorsogluteal site.
Sources for this answer
- Vocabria 600 mg prolonged-release suspension for injectionViiV Healthcare UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 10Document updated
Sources checked